Motivation and barriers to participation in clinical trials

被引:11
作者
Gaul, Charly
Schmidt, Thomas
Helm, Juergen
Hoyer, Heike
Haerting, Johannes
机构
[1] Univ Halle Wittenberg, Neurol Klin & Poliklin, D-06097 Halle, Germany
[2] Univ Halle Wittenberg, Koordinierungszentrum Klin Studien Halle, D-06097 Halle, Germany
[3] Univ Halle Wittenberg, Inst Geschichte & Eth Med, D-06097 Halle, Germany
[4] Univ Halle Wittenberg, Inst Med Epidemiol Biometrie & Informat, D-06097 Halle, Germany
关键词
D O I
10.1007/s00063-006-1116-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Clinical trials are essential in clinically orientated medical research. Enrollment of patients is determined by patient-related barriers, protocol-related barriers, and motivation and behavior of the physician. Main Theses: Patients enrollment in clinical trials is determined by disease, possible diagnostic or therapeutic benefit of study procedures, effort of protocol procedures, and trustfulness of the relationship between the physician and patient. Randomized trials, extensive study procedures and the possibility of receiving placebo are barriers to participation. Understanding of the communication process and knowledge of patients' needs are the base education to gain patients' informed consent to enter a clinical trial and a stable compliance in the course of the study. Motivation of physicians to enroll patients in a clinical trial is determined, e.g., by environmental conditions in clinic or doctors' office, the time and effort of study procedures, and individual academic interest. Conclusion: Awareness of factors (positive and negative) which influence motivation of participation in a clinical trial is useful to provide strategies for successful enrollment of patients.
引用
收藏
页码:873 / 879
页数:7
相关论文
共 19 条
[1]   Patients' willingness to participate in placebo-controlled trials of antihypertensive therapy [J].
Al-Khatib, SM ;
Sen Biswas, M .
AMERICAN HEART JOURNAL, 2003, 146 (06) :944-945
[2]   Strategic physician communication and oncology clinical trials [J].
Albrecht, TL ;
Blanchard, C ;
Ruckdeschel, JC ;
Coovert, M ;
Strongbow, R .
JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (10) :3324-3332
[3]   Problems in recruiting community-based physicians for health services research [J].
Asch, S ;
Connor, SE ;
Hamilton, EG ;
Fox, SA .
JOURNAL OF GENERAL INTERNAL MEDICINE, 2000, 15 (08) :591-599
[4]   PATIENTS ATTITUDES TO PARTICIPATION IN CLINICAL-TRIALS [J].
BEVAN, EG ;
CHEE, LC ;
MCGHEE, SM ;
MCINNES, GT .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1993, 35 (02) :204-207
[5]  
de Wit N J, 2001, J Fam Pract, V50, P976
[6]   Patient recruitment: the costly and growing bottleneck in drug development [J].
Drennan, KB .
DRUG DISCOVERY TODAY, 2002, 7 (03) :167-170
[7]   INFORMATION PREFERENCES OF PATIENTS WITH CANCER [J].
FALLOWFIELD, L ;
FORD, S ;
LEWIS, S .
LANCET, 1994, 344 (8936) :1576-1576
[8]  
Ferguson P R, 2001, Med Law, V20, P143
[9]   Learning from the TGN1412 trial - This experience should foster an open culture in medical research [J].
Goodyear, M .
BRITISH MEDICAL JOURNAL, 2006, 332 (7543) :677-678
[10]   Determinants of patient recruitment in a multicenter clinical trials group: Trends, seasonality and the effect of large studies [J].
Haidich A.-B. ;
Ioannidis J.P.A. .
BMC Medical Research Methodology, 1 (1) :1-11